Analytical Data
-
Gene name
IMMP2L
- Application
-
Alternative Names
IMMP2L;Mitochondrial inner membrane protease subunit 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96T52
-
Expression Region
38-175aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSRVEGASM QPSLNPGGSQ SSDVVLLNHW KVRNFEVHRG DIVSLVSPKN PEQKIIKRVI ALEGDIVRTI GHKNRYVKVP RGHIWVEGDH HGHSFDSNSF GPVSLGLLHA HATHILWPPE RWQKLESVLP PERLPVQREE E
-
Molecular Weight
18 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
IMMP2L (Immp2-like Protein) is a gene that encodes a protein involved in mitochondrial function and development, playing a crucial role in maintaining cellular homeostasis. Recent studies have indicated that IMMP2L may be associated with various neurological disorders, particularly those affecting cognitive functions. Its expression and function are critical in neuronal cells, and any perturbation can lead to mitochondrial dysfunction and, consequently, neuronal degeneration. Understanding the molecular mechanisms underlying IMMP2L is essential, as it may illuminate pathways involved in neurodegenerative diseases and offer potential therapeutic targets. The study of IMMP2L recombinant proteins has gained traction, aiming to decipher its structural and functional properties, which could facilitate the development of novel diagnostic and therapeutic strategies. By producing and characterizing IMMP2L in a recombinant system, researchers can investigate its interaction with other mitochondrial proteins and its role in cellular processes, thereby contributing to a more comprehensive understanding of mitochondrial biology and its implications in human health and disease. This research is particularly significant given the increasing prevalence of neurodegenerative diseases in aging populations, making the exploration of IMMP2L both timely and essential for future biomedical advances.
